ecancer

ecancer.org

ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.

 

ESMO 2022: Fruquintinib Provides Improvement in Overall Survival for Refractory mCRC

By ecancer FEATURING Arvind Dasari
By ecancer FEATURING Arvind Dasari
9 views
September 30, 2022
0 Comments
Login to view comments. Click here to Login
ESMO 2022